NCT06489808 Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL Status RECRUITING Phase PHASE2
NCT06480864 Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase NA
NCT06478264 A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06467357 Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer Status RECRUITING Phase PHASE3
NCT06465563 SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06457503 A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer Status RECRUITING Phase PHASE4
NCT06452277 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) Status RECRUITING Phase PHASE3
NCT06446726 Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06446388 Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors Status NOT_YET_RECRUITING Phase PHASE2
NCT06445114 Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer Status RECRUITING Phase PHASE2
NCT06440993 Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT06431633 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. Status RECRUITING Phase PHASE3
NCT06428409 A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) Status RECRUITING Phase PHASE1/PHASE2
NCT06426056 Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial. Status NOT_YET_RECRUITING Phase PHASE2
NCT06423326 Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT06422858 Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06419673 Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06417814 A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06406465 A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity Status RECRUITING Phase PHASE2
NCT06387056 Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) Status RECRUITING Phase PHASE2